Vimarsana
Biggest News Aggregation in the World

Analyse Sample News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analyse Sample. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analyse Sample Today - Breaking & Trending Today

Week In Review: Fosun Signs $840 Million Deal For U.S. Rights To Henlius' PD-1 - Vimarsana News

Week In Review: Fosun Signs $840 Million Deal For U.S. Rights To Henlius' PD-1

Published: November 21, 2022

Shanghai Fosun Pharma announced it has licensed US rights to a PD-1 candidate from its longstanding partner Henlius Biotech in an $840 million agreement. Read more here...

Source: seekingalpha.com
Related Topics:
United StatesYifan PharmaMarinus ZtalmyMarinus PharmaXiaochun YuFosun PharmaZhuhai BiotheusJiangsu Hansoh PharmaSimcere PharmaCompany NewsResearch LaboratoryInnovative TechnologyScientific Lab For MedicineModern Medical Research LaboratoryTwo Scientists Wearing Face MasksAnalyse SamplePetri DishDiscuss InnovativeAdvanced Scientific LabHenlius BiotechAlthough FosunEvive BiotechnologyAcrotech BiotechGranulocyte Colony Stimulating FactorHansoh Pharma
Annexon Stock: A First Take (NASDAQ:ANNX) - Vimarsana News

Annexon Stock: A First Take (NASDAQ:ANNX)

Published: August 21, 2022

Shares of clinical-stage biopharma Annexon are down by half since an early January 2022 data release revealed 5 of 28 patients dropped out of a Phase 2 Huntington’s disease study.

Source: seekingalpha.com
Related Topics:
United StatesTruman CapoteMuneer SatterCompany OverviewResearch LaboratoryInnovative TechnologyScientific Lab For MedicineAnnexon IncModern Medical Research LaboratoryTwo Scientists Wearing Face MasksAnalyse SamplePetri DishDiscuss InnovativeAdvanced Scientific LabGuillain Barre SyndromeNorth AmericaOrphan DrugFast TrackAnalyst Commentary